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Objective
• In an insulin delivery system (insulin recommender or
artificial pancreas), a safety layer is paramount in order to
minimise risk of adverse events (hypo- and hyperglycaemia)
due to potential malfunctioning of the system
(algorithm/sensor/pump).
• This work presents a novel safety layer which includes: a
dynamic insulin constraint; a predictive low-glucose insulin
suspend; and an adaptive carbohydrate recommender.
Methods
Dynamic Insulin Constraint
• An insulin bolus calculator in which, parameters (ICR, ISF),
inputs (Carbs, Glucose), insulin-on-board (IOB) and output
(Bolus) are considered to be numerical intervals [1]
representing measurement, estimation errors and insulin
requirements variability, is employed.
• Insulin doses from the delivery system are constrained by the
resulting interval bounds of the bolus calculation.
Predictive Low-glucose Suspend (LGS)
• The employed glucose forecasting algorithm is based on a
composite minimal model of insulin-glucose dynamics [2]
and a deconvolution technique [3] to estimate plasma glucose
rate of appearance. Only one parameter is individualised.
• Basal insulin is halved, or suspended, once the predicted
glucose crosses two predefined thresholds.
Adaptive Carbohydrate Recommender
• Once a predefined glucose threshold is crossed, a carbohydrate
dose (CHO) is computed based on the error between the
predicted glucose (GP), a predefined target (GT), the
carbohydrate sensitivity factor (CSF) and an estimation of the
carbohydrate-on-board (COB).
• A Run-to-Run control algorithm is employed to
automatically adapt the carbohydrate sensitivity factor (CSF).
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PEPPER Project
• PEPPER is an EU-funded project aiming to develop a
mobile-based platform that will help people with type 1
diabetes to improve self-management of their condition [4].
• Together with an AI-based insulin recommender, the
proposed safety layer is part of the PEPPER system, which
has been implemented on a mobile platform and is about to be
clinically tested.
Results
• In silico results with the UVa-Padova simulator (n=10 adults)
show that the dynamic insulin constraint is able to eliminate
severe hypoglycaemia (<50mg/dL) and severe
hyperglycaemia (>400mg/dL) under realistic variability.
• Retrospective clinical tests show that the implemented glucose
forecasting algorithm outperforms a state-of-the-art
algorithm (AR model (order 3) with recursive identification)
(rRMSE: 24.2% vs. 32.6% - horizon: 90min).
• When tested in silico (n=10 adults), the predictive low-
glucose suspend significantly reduces the % time spent in
hypoglycaemia (<70mg/dL) (3.2±3.5 vs. 0.71±0.96, p<0.05)
without increasing the % time spent in hyperglycaemia
(>180mg/dL) (18.7±10.0 vs. 19.6±8.2, p=0.3).
• In silico results (n=10 adults) show that the carbohydrate
recommender significantly reduces the % time spent in
hypoglycemia (3.2±3.5 vs. 0.77±1.08), p<0.05) without
increasing the % time spent in hyperglycaemia 18.7±10.0 vs.
19.1±9.1, p=0.3).
Conclusion
• A novel safety layer for insulin dosing systems has the
potential to improve glycaemic control in an adult type 1
population.
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